A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL)John G. Gribben, Mark W. Frohlich, Ralph V. Boccia et al.|Transplantation and Cellular Therapy|2005Cited by 1
A phase I/II study of Xcellerated T Cells in patients with chronic lymphocytic leukemiaTJ Kipps, Mark W. Frohlich, William G. Wierda et al.|Journal of Clinical Oncology|2005Cited by 1